Gastritis / GERD / Peptic Ulcer Disease (NSAID-Induced) Secondary to Chronic Pain Condition (Service-Connected)

Yes. Under 38 CFR § 3.310(a), any disability proximately caused or chronically worsened by a service-connected condition is itself service-connected. Gastritis / GERD / Peptic Ulcer Disease (NSAID-Induced) is a documented secondary pairing for Chronic Pain Condition (Service-Connected) with strong medical evidence. A nexus letter from a qualified physician linking the two conditions is the most reliable way to establish this connection.

The gold standard is a private nexus opinion stating — to at least a 50% probability ("at least as likely as not") — that the secondary condition was caused or aggravated by the primary service-connected condition. Peer-reviewed medical literature supporting the physiological mechanism strengthens the nexus. Treatment records documenting the onset or worsening of the secondary condition in temporal relation to the primary are supporting evidence.

The VA rates Gastritis / GERD / Peptic Ulcer Disease (NSAID-Induced) separately under its own 38 CFR Part 4 diagnostic code, then combines it with Chronic Pain Condition (Service-Connected) and all other service-connected ratings using the combined ratings formula under § 4.25. The formula applies the whole-person concept: a 50% combined existing rating plus a new 30% rating yields 65% (rounded to 70%), not 80%.

38 CFR § 3.310(a) states: "Disability which is proximately due to or the result of a service-connected disease or injury shall be service connected." The aggravation variant under § 3.310(b) applies where the primary condition permanently worsens a pre-existing disability beyond its natural progression. Both standards require a showing of nexus — a medical or scientific link between the primary condition and the secondary.

The medical evidence supporting Gastritis / GERD / Peptic Ulcer Disease (NSAID-Induced) as secondary to Chronic Pain Condition (Service-Connected) is rated strong. NSAIDs (ibuprofen, naproxen, ketorolac, meloxicam, celecoxib) are among the most commonly prescribed medications for service-connected musculoskeletal pain conditions. Chronic NSAID use is the second most common cause of peptic ulcer disease and GI bleeding after H. pylori. Mechanism: NSAIDs inhibit COX-1 (the constitutive cyclooxygenase), suppressing prostaglandin E2 (PGE2) production in the gastric mucosa. PGE2 is essential for stimulating mucus and bicarbonate secretion, maintaining mucosal blood flow, and promoting mucosal cell proliferation. Without PGE2, the gastric mucosa loses its protective barrier against luminal acid, producing gastritis, erosions, and ulceration. NSAID-induced gastropathy produces ulcers in 15–25% of chronic users and is responsible for approximately 16,500 deaths annually in the United States. This is a well-established drug-disease nexus directly rateable as secondary to the pain condition requiring NSAID use.

The VA will not solicit nexus evidence on your behalf for secondary claims. In practice, a written nexus opinion from a private physician or independent medical examiner is essential — the VA's Compensation & Pension (C&P) examiner is not required to produce a favorable nexus opinion, and the VA has discretion to weigh competing opinions. Submitting a private nexus letter at the time of filing is the most reliable strategy.